tirzepatide eu approval regulator recommends Eli Lilly's Mounjaro for weight management Mounjaro | European Medicines Agency

In their separate trials, retatrutides top dose produced a higher average weight loss (28.3%) than Mounjaros (22.5% in SURMOUNT-1), a difference of roughly 6 percentage points

The common injection sites are: Abdomen (Stomach) Thigh Back Of The Upper Arm (often easiest if someone can help) How to Inject Tirzepatide Step By Step Before you begin, confirm that youre using the exact dose your clinician prescribed and read your devices Instructions for Use (pens and syringes have different instructions)

In one study, more than half the participants (54%) had no previous use of oral glucose-lowering medication [22], while in another study, all participants were on a stable dose of insulin glargine with (83%) or without (17%) metformin [19]

The combined efforts of pharmaceutical companies, healthcare providers, and patients are pivotal in pushing for more inclusive and affordable healthcare solutions

What if the medication stops working

While tirzepatide may be associated with hair loss as reported in clinical trials, the substantial weight loss it produces can trigger a well-recognized condition called telogen effluvium